Dimerix (ASX: DXB) Discussion Thread, page-430

Phase III Interim Results ,,, Phase III is heavily monitored , haven't seen any major adverse effects , Phase III is generally How effective a Treatment is , its not really a Binary Outcome , Pass Fail, Go Stop etc ,,,
When you have Physicians recommend that their Patients stay on a Medication ( a non regulated or approved Medication ) you know that there would be evidence that the medication has demonstrated "Patient Benefit"

My main Holding here is averaging 9c so well exceeded my normal margin ,, I can see DXB surpassing 40c possibly 50c , I wont be here long after that as I'll be back over on BOT for the FDA Approval ,, plus I have a few near term opportunities in between ,,

Great year for Biotech so far,,long may it continue NZT